Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
Folotyn
fosaprepitant
fosnetupitant
Fotivda
FP Gastric Cancer Leukemia
FR
FUDR
fulvestrant Breast Cancer Fulvestrant
futibatinib Futibatinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
gastric cancer
gastrointestinal stromal tumor (GIST)
Gavreto
Gazyva
GCB
GCP
G-CSF Bladder Cancer Endometrial Cancer Esophageal Cancer Head and Neck Cancer Leukemia Lung Cancer Lymphoma Osteogenic Sarcoma Soft Tissue Sarcomas Thymoma
gefitinib Gefitinib Lung Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
GEM-CAP
gemcitabine
gemtuzumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
gemtuzumab ozogamicin
Gemzar
Gilotrif
gilteritinib Gilteritinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
glasdegib Glasdegib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Gleevec
glofitamab
goserelin Breast Cancer Goserelin Prostate Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
goserelin hydroxyurea
granisetron Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: